Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Medecine Et Maladies Infectieuses|August 31, 2010
[Genetic barrier to antiretroviral drug-resistance. Focus on raltegravir, the first integrase inhibitor]C Delaugerre
Virologie (Montrouge, France)|November 4, 2021
[HIV resistance to non-nucleoside reverse transcriptase inhibitors]C Delaugerre, M-L Chaix
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|February 9, 2007
[HIV-1 drug resistance in French infected-children: from newborn to adolescent]C Delaugerre, M-L Chaix, J Warszawski, et al.
British Journal of Rheumatology|February 11, 1999
GB virus C in systemic medium- and small-vessel necrotizing vasculitidesA Servant, M Bogard, C Delaugerre, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2016
Pre-exposure prophylaxis: a useful tool to prevent human immunodeficiency virus infection?G Pialoux, C Delaugerre, L Cotte, et al.
Gynecologie, Obstetrique & Fertilite|August 30, 2005
[Male genital tract infection: the point of view of the virologist]M Leruez-Ville, J Galimand, J Ghosn, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 16, 2013
Analytical sensitivity of three real-time PCR assays for measuring subtype B HIV-1 RNAK Sauné, C Delaugerre, S Raymond, et al.
Journal of Virology|December 19, 2000
Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infectionG Carcelain, R Tubiana, A Samri, et al.
HIV Medicine|September 22, 2012
Longitudinal analysis of integrase N155H variants in heavily treated patients failing raltegravir-based regimensH L Nguyen, C Charpentier, N Nguyen, et al.
Journal of Medical Virology|October 12, 2001
Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimenC Delaugerre, R Rohban, A Simon, et al.
Pageof 4